Augmedix (NASDAQ:AUGX) reported results for the first quarter of 2024.
- Augmedix reported earnings per share of -12 cents. This was above the analyst estimate for EPS of -13 cents.
- The company reported revenue of $13.47 million.
- This was 0.76% better than the analyst estimate for revenue of $13.37 million.
No comments:
Post a Comment